Loading...
Inhibition of mTORC1 signaling reduces tumor growth but does not prevent cancer progression in a mouse model of thyroid cancer
Selective drugs targeting dysregulated oncogenic pathways are promising cancer therapies. Because the mammalian target of rapamycin complex 1 (mTORC1) pathway is hyperactivated in human follicular thyroid cancer (FTC), we hypothesized that its inhibition could block cancer development and progressio...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2893796/ https://ncbi.nlm.nih.gov/pubmed/20299527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/carcin/bgq059 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|